|
Symbol
|
YVALTQ | Z09BLZ | Z0B8QZ | MATRCH | MABBJB | MAPTJB | ZMAH5V | MAQGJB | MAKGJB | LVCXLK | MAFQJB | MASEJB | AAZMSP | AHVDTQ | LGBTLK |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Express Certificate | Express Note* | Express Note* | Worst of Express Certificate | Express Certificate | Express Certificate | Express Voncert* | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible | Multi Express Certifikat with European Knock-In | Multi Express Certifikat with European Knock-In | Autocallable Notes | Express Certificate with European Knock-In | LUKB Autocallable Multi Barrier Reverse Convertible |
|
Basiswert
|
Johnson & Johnson / Nestlé S.A. / Roche PS / Swiss RE AG | Nestlé S.A. / Roche PS / Swisscom N | Novo Nordisk AS-SPONS ADR / Roche PS / Teva Pharmaceutical Industries Ltd. | Compagnie Financière Richemont SA / Lonza Group N / Roche PS / Sika AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Novo Nordisk, AstraZeneca, Roche, Novartis Basket | AstraZeneca Plc. / Novartis AG / Roche PS / Sanofi S.A. | Nestlé S.A. / Roche PS |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
24.03.2028 | 25.03.2027 | 24.06.2027 | 10.05.2028 | 04.11.2026 | 04.11.2026 | 30.10.2026 | 30.04.2029 | 30.04.2029 | 12.08.2027 | 05.01.2029 | 05.01.2029 | 07.10.2033 | 21.03.2028 | 13.10.2028 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Geld | 93.38 | - | - | 95.57 | - | - | - | - | - | - | - | - | - | 101.57 | - |
| Brief | - | - | - | 96.37 | - | - | - | - | - | - | - | - | - | 102.39 | - |